118 related articles for article (PubMed ID: 27225230)
1. The discovery of allyltyrosine based tripeptides as selective inhibitors of the HIV-1 integrase strand-transfer reaction.
Dalton N; Gordon CP; Boyle TP; Vandegraaf N; Deadman J; Rhodes DI; Coates JA; Pyne SG; Keller PA; Bremner JB
Org Biomol Chem; 2016 Jul; 14(25):6010-23. PubMed ID: 27225230
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
[TBL] [Abstract][Full Text] [Related]
4. The complestatins as HIV-1 integrase inhibitors. Efficient isolation, structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I.
Singh SB; Jayasuriya H; Salituro GM; Zink DL; Shafiee A; Heimbuch B; Silverman KC; Lingham RB; Genilloud O; Teran A; Vilella D; Felock P; Hazuda D
J Nat Prod; 2001 Jul; 64(7):874-82. PubMed ID: 11473415
[TBL] [Abstract][Full Text] [Related]
5. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
[TBL] [Abstract][Full Text] [Related]
7. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
[TBL] [Abstract][Full Text] [Related]
8. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
9. Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
Deng J; Sanchez T; Al-Mawsawi LQ; Dayam R; Yunes RA; Garofalo A; Bolger MB; Neamati N
Bioorg Med Chem; 2007 Jul; 15(14):4985-5002. PubMed ID: 17502148
[TBL] [Abstract][Full Text] [Related]
10. 3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase.
Tang J; Maddali K; Metifiot M; Sham YY; Vince R; Pommier Y; Wang Z
J Med Chem; 2011 Apr; 54(7):2282-92. PubMed ID: 21381765
[TBL] [Abstract][Full Text] [Related]
11. Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
Li BW; Zhang FH; Serrao E; Chen H; Sanchez TW; Yang LM; Neamati N; Zheng YT; Wang H; Long YQ
Bioorg Med Chem; 2014 Jun; 22(12):3146-58. PubMed ID: 24794743
[TBL] [Abstract][Full Text] [Related]
12. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
13. Targeting HIV-1 integrase with strand transfer inhibitors.
Li Y; Xuan S; Feng Y; Yan A
Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
[TBL] [Abstract][Full Text] [Related]
14. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
Dayam R; Sanchez T; Neamati N
J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
[TBL] [Abstract][Full Text] [Related]
15. Hydrazide-containing inhibitors of HIV-1 integrase.
Zhao H; Neamati N; Sunder S; Hong H; Wang S; Milne GW; Pommier Y; Burke TR
J Med Chem; 1997 Mar; 40(6):937-41. PubMed ID: 9083482
[TBL] [Abstract][Full Text] [Related]
16. Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: azoles: effective metal chelators.
Le G; Vandegraaff N; Rhodes DI; Jones ED; Coates JA; Thienthong N; Winfield LJ; Lu L; Li X; Yu C; Feng X; Deadman JJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5909-12. PubMed ID: 20727753
[TBL] [Abstract][Full Text] [Related]
17. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
[TBL] [Abstract][Full Text] [Related]
19. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW
J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]